Previously, Dr. Mailk was the medical director of the hepatology and hepatobiliary program at Beth Israel Deaconess Medical Center in Boston, where he developed l programs to treat liver cancer and liver failure.
Dr. Malik earned his medical degree from King’s College London and his PhD in cell biology and hepatology at University College London, both in England.
More articles on gastroenterology:
CMS changes coming to GI practices & 4 other must-read articles
GI leader to know: Dr. Robin Rothstein of Temple University Hospital
Exact closes its $2.8B acquisition & more: 7 GI industry key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.